Condition
Huntington Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 31 Huntington Disease clinical trials that are recruiting, at sites in 32 countries (most in United States (15), France (8), Belgium (5)). By phase: Phase 2 (3), Phase 1/2 (3), Phase 3 (2), Early Phase 1 (1). The most active sponsors are University of Central Florida (2), Assistance Publique - Hôpitaux de Paris (2). There are also 11 NIH-funded research projects on Huntington Disease, with $4.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 31Clinical trials
- 11NIH research projects
- 32Countries
Newest Huntington Disease clinical trials
All recruiting trials (31)
-
Pridopidine for Huntington's Disease: a 1-year, randomized, placebo-controlled study
This trial tests whether pridopidine can slow the progression of Huntington's disease in adults compared with placebo over one year.
-
Low-intensity focused ultrasound targeting the globus pallidus to improve movement in Huntington's disease
This trial tests whether different pulse frequencies of low-intensity focused ultrasound (LIFU) aimed at a deep brain target can safely reduce chorea and other motor symptoms in adults with Huntington's disease.
-
Safety and tolerability of human neural stem cell implants for Huntington's disease
This research will test whether an implant of hNSC-01 human neural stem cells is safe and tolerable for adults with Huntington's disease.
-
SKY-0515 for adults with Huntington's disease
This trial will test whether the oral drug SKY-0515 can lower harmful huntingtin protein and improve symptoms in adults aged 25 and older with genetically confirmed Huntington's disease.
-
Votoplam for adults with early symptomatic Huntington's disease
This trial will test whether votoplam (HTT227) is safe and can slow disease progression in adults with early symptomatic Huntington's disease.
-
Comparing three social cognition tests in adults with early Huntington disease
This project will test whether the DMASC-MC and two established social cognition tests can detect social thinking problems in adults with early Huntington disease.
-
Wearable monitoring of walking and arm movement in adults with neuromuscular or metabolic movement disorders
This project uses a wrist/ankle wearable to continuously monitor walking and upper-limb movement in ambulant adults with neuromuscular diseases or obesity to see if digital measures like stride speed track real-life motor function.
-
Wearable sensors to track walking and involuntary movements in Huntington's disease
This study will try whether wrist and body-worn sensors plus virtual visits can track gait changes and chorea in adults with Huntington's disease and in healthy adults.
-
Biobank for monitoring and understanding Huntington's disease
This study is trying to find new ways to track Huntington's disease by using home monitoring and tests to see how it changes over time for people living with the condition.
-
Investigating Nicotinamide Riboside for Huntington's Disease
This study is testing if a vitamin B3 supplement called nicotinamide riboside can help slow down Huntington's disease in adults compared to a placebo.
-
Home-based tDCS to help thinking and behavior in Huntington's disease
This project will test whether daily at-home transcranial direct current stimulation (tDCS) can help thinking and behavioral symptoms in adults with early-to-moderate Huntington's disease.
-
Gene therapy for Huntington's Disease using SPK-10001
This study is testing a new gene therapy called SPK-10001 to see if it can safely help people with Huntington's Disease feel better.
-
Hinting Task to measure social thinking in Huntington's disease
This research will test whether the Hinting Task can reliably measure Theory of Mind (social thinking) in Dutch-speaking adults with Huntington's disease.
-
New PET tracer ([11C]CHDI-00491009) to image mutant huntingtin in Huntington disease
This project will test a new PET tracer ([11C]CHDI-00491009) to see if it binds mutant huntingtin aggregates in adults with Huntington disease and in healthy volunteers.
-
Investigating early biomarkers in gene carriers of Huntington's disease
This study is testing if brain scans and virtual reality can help find early signs of Huntington's disease in people who carry the gene but don't have symptoms yet.
-
Using SAGE and a Coding test to check thinking skills in Huntington's disease
We will test whether two quick thinking tests—the Self‑Administered Gerocognitive Examination (SAGE) and a Coding test—work well for adults with genetic Huntington's disease.
-
Collecting health information from individuals with Huntington Disease
This study is collecting health information from people with Huntington Disease to better understand how the condition affects them over time using an online platform.
-
Gut bacteria in Huntington disease
This project will try to see if adults with Huntington's disease who worsen quickly have different gut bacteria than those who progress more slowly.
-
Evaluating music therapy for irritability and impulsivity in Huntington's disease
This study is testing if music therapy can help reduce irritability and impulsivity in people with early-stage Huntington's disease.
-
Biobank for studying ALS and Alzheimer's diseases
This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.
-
Non-invasive prenatal diagnosis for single gene disorders
This study is testing a new way to safely diagnose single-gene disorders in unborn babies using a simple blood test from the mother, starting as early as 9 weeks into the pregnancy.
-
Using blood samples to find biomarkers for Huntington Disease
This study is trying to find signs in blood samples that could help track Huntington Disease by looking at tiny particles released from brain cells in people with the disease compared to healthy individuals.
-
Testing a new drug VO659 for genetic neurodegenerative diseases
This study is testing a new drug called VO659 to see if it is safe and can help people with spinocerebellar ataxia types 1 and 3 or Huntington's disease.
-
Using new imaging and cognitive biomarkers to predict progression in Huntington's disease
This study is testing new imaging and brain function markers to see if they can help predict how Huntington's disease will progress in people who have it and those who might get it in the future.
-
Testing N-Acetyl Cysteine for people at risk of Huntington's Disease
This study is testing if taking N-Acetyl Cysteine can help people who are at risk for Huntington's Disease delay the start of symptoms.
-
Comparing two PET imaging techniques in Huntington Disease
This study is testing two different PET imaging techniques to see which one better shows changes in the brain of people with Huntington Disease and how those changes relate to movement problems.
-
Home-based brain stimulation for symptoms in Huntington's Disease
This study is testing if a type of brain stimulation can help people with Huntington's Disease feel better by reducing symptoms like apathy, irritability, and depression.
-
Combined Thiamine and Biotin Treatment for Huntington's Disease
This study is testing if a combination of thiamine and biotin can help slow down symptoms in people with mild to moderate Huntington's disease.
-
Evaluating BDNF Biomarkers in Cerebrospinal Fluid for Huntington's Disease
This study is testing if measuring a protein in the spinal fluid can help understand Huntington's Disease better and see how it relates to the disease's severity and brain changes.
-
Longitudinal imaging of brain changes in Huntington's disease
This study looks at brain changes in people with Huntington's disease over three years to see how it progresses and to find possible signs that could help in future treatments.
-
Evaluating retinal imaging for neurodegenerative diseases
This study is testing if special eye scans can help spot early signs of neurodegenerative diseases like Alzheimer's and Parkinson's in people.
NIH-funded research (11)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Harnessing neuron-derived vesicles to find Huntington’s disease biomarkers
A research project aims to identify brain-derived biomarkers in blood that reflect Huntington disease activity, using neuronal extracellular vesicles as the signal source.
-
Understanding how blood flow problems in the brain affect Huntington’s disease
A study at a major hospital is looking at how blood vessels in the brain may contribute to symptoms and brain changes in Huntington’s disease.
-
Rhes‑SUMO pathway's role in Huntington's disease
This work looks at whether the Rhes‑SUMO protein system increases toxic huntingtin and helps it spread in the brain, which may explain early striatal damage in people with Huntington's disease.
-
Understanding how ribosome stalling affects Huntington disease
This study is looking at how a problem with protein production in the brain might contribute to Huntington disease, which could help us find new ways to treat the condition.
-
Rhes-SUMO Pathway and Huntington Disease in Mice
A study in mouse models explores how the Rhes-SUMO pathway may drive brain and nerve cell vulnerability in Huntington disease.
-
Investigating the role of the Rhes-SUMO pathway in Huntington's disease
This study is looking at how a specific pathway in the brain might affect the worsening of Huntington's disease, with the hope of finding new ways to help manage the symptoms and slow down the disease for those living with it.
-
Understanding how Huntington disease disrupts protein production in brain cells
Researchers are studying Huntington disease to learn how a faulty protein blocks ribosomes and slows protein-making in brain cells, which may contribute to movement and thinking problems.
-
Investigating the role of the Rhes-SUMO pathway in Huntington's disease
This study is looking at how a specific pathway in the brain might affect the progression of Huntington's disease, with the hope of finding new ways to help manage or treat the condition for patients.
-
How Blood Vessel Changes in the Brain Affect Huntington's Disease
This work explores how changes in brain blood vessels might contribute to the symptoms and progression of Huntington's disease in people living with the condition.
-
Understanding behavior in youth at risk for Huntington disease
This study is looking at the thinking and behavior challenges that young people at risk for Huntington disease might face, like trouble with decision-making, anxiety, and acting impulsively, to help find early signs and improve support for them before any physical symptoms appear.
-
Investigating a new pathway in Huntington's disease
This study is looking at how a specific pathway in the brain might affect nerve cell health in people with Huntington's disease, with the hope of finding new ways to help improve their condition.
Related topics
Quick answers
How many Huntington Disease clinical trials are recruiting right now?
31, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 32 countries. The most sites are in United States (15 trials), France (8 trials), Belgium (5 trials), United Kingdom (5 trials), Germany (4 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 3, Phase 3: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.